DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
August 26, 2021 — The Sickle Cell Disease Association of America Medical and Research Advisory Committee reminds the sickle cell community that the COVID-19 pandemic is not over and that news is moving quickly in many areas.
MARAC recommendations are making a minor shift to emphasize a more individualized approach:
- Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect changes in CDC guidance.
- Continue to recommend general precautions: wearing masks, keeping physical distancing, good ventilation, and washing hands. These are public health measures.
- Recommend neutralizing monoclonal antibodies (mAb) – (Regeneron) as early treatment for mild symptomatic COVID in individuals with SCD [<10d after the test, age 12y+, wt 88 lb+ (40kg+), not hospitalized, not newly on oxygen]. Encourage getting tested if you have COVID symptoms. Possible prophylactic treatment with Regeneron antibodies if exposed to COVID.
- No general recommendation for all individuals with SCD to stay home nor all to return to in-person activities. Help patients and families make individualized assessments of risk and trade-offs of returning to work or school in-person. Factors to consider were listed in MARAC July 2020 “checklist for return to school” (plus vaccination status): the community’s rates of COVID and variants, vaccination status, family socioeconomic situation, ventilation and other protective measures in the building, mental health needs, educational needs.
Read the full statement for more information on the above.
education & researchPerspectives and practices of athletic trainers and team physicians implementing the 2010 NCAA sickle cell trait scr...Sickle cell trait (SCT) is usually benig...
news & eventsSCDAA Partners With Phi Beta Sigma FraternityThe Sickle Cell Disease Association of A...
news & eventsHealth+ Sickle Cell Disease HealthathonHHS and Howard University are hosting a ...
people & placesGlory’s Hope Sickle Cell FoundationSickle Cell Disease is a painful disease...
Community CenterToday’s Faces of Sickle Cell Disease: Marqus ValentineWhen Marqus Valentine went to junior col...
videos & visualsASH Clinical Practice Guidelines on Sickle Cell Disease (SCD)https://www.youtube.com/watch?v=tozUcTSN...
videos & visualsA Patient’s Journey With Sickle Cell Diseasehttps://www.youtube.com/watch?v=h8ZetdyY...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.